Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Investment analysts at KeyCorp lowered their FY2018 earnings estimates for Acadia Healthcare in a research note issued on Wednesday. KeyCorp analyst J. Gurda now anticipates that the company will post earnings per share of $2.46 for the year, down from their prior estimate of $2.84. KeyCorp has a “Buy” rating and a $59.00 price target on the stock. KeyCorp also issued estimates for Acadia Healthcare’s FY2019 earnings at $2.73 EPS.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.65 by ($0.07). The company had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a return on equity of 8.57% and a net margin of 6.07%. The firm’s revenue was down 2.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.58 earnings per share.

COPYRIGHT VIOLATION WARNING: “Acadia Healthcare Company, Inc. (ACHC) Expected to Post FY2018 Earnings of $2.46 Per Share” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/10/30/acadia-healthcare-company-inc-achc-expected-to-post-fy2018-earnings-of-2-46-per-share.html.

ACHC has been the topic of a number of other research reports. William Blair initiated coverage on shares of Acadia Healthcare in a research note on Tuesday, July 18th. They issued an “outperform” rating on the stock. BMO Capital Markets began coverage on Acadia Healthcare in a research report on Monday, October 16th. They issued an “outperform” rating and a $52.00 target price for the company. Zacks Investment Research lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Thursday, October 12th. Mizuho set a $60.00 price target on shares of Acadia Healthcare and gave the company a “buy” rating in a research report on Tuesday, October 24th. Finally, Jefferies Group LLC set a $60.00 price target on shares of Acadia Healthcare and gave the company a “buy” rating in a research report on Wednesday, October 11th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. Acadia Healthcare currently has a consensus rating of “Buy” and a consensus target price of $47.46.

Shares of Acadia Healthcare (ACHC) traded down 2.41% on Monday, reaching $32.45. 488,515 shares of the company traded hands. The stock’s 50 day moving average price is $44.40 and its 200-day moving average price is $46.07. Acadia Healthcare has a one year low of $30.91 and a one year high of $54.34. The stock has a market capitalization of $2.85 billion, a P/E ratio of 356.59 and a beta of 1.07.

A number of hedge funds and other institutional investors have recently modified their holdings of ACHC. American Assets Investment Management LLC raised its stake in shares of Acadia Healthcare by 11.4% in the third quarter. American Assets Investment Management LLC now owns 84,370 shares of the company’s stock worth $4,030,000 after purchasing an additional 8,650 shares during the last quarter. Crossmark Global Holdings Inc. purchased a new position in shares of Acadia Healthcare in the third quarter worth about $441,000. Pictet Asset Management Ltd. purchased a new position in shares of Acadia Healthcare in the third quarter worth about $11,324,000. State of New Jersey Common Pension Fund D raised its stake in shares of Acadia Healthcare by 16.7% in the third quarter. State of New Jersey Common Pension Fund D now owns 700,000 shares of the company’s stock worth $33,432,000 after purchasing an additional 100,000 shares during the last quarter. Finally, Aperio Group LLC raised its stake in shares of Acadia Healthcare by 4.8% in the third quarter. Aperio Group LLC now owns 30,187 shares of the company’s stock worth $1,442,000 after purchasing an additional 1,370 shares during the last quarter.

In related news, EVP Christopher L. Howard sold 16,762 shares of the firm’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $52.47, for a total transaction of $879,502.14. Following the sale, the executive vice president now owns 200,999 shares of the company’s stock, valued at $10,546,417.53. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director William Grieco sold 2,000 shares of the firm’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $51.71, for a total value of $103,420.00. Following the sale, the director now directly owns 45,013 shares in the company, valued at approximately $2,327,622.23. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,842,802 shares of company stock worth $93,443,510. Insiders own 11.10% of the company’s stock.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.